Lilly(LLY) - 2025 Q3 - Earnings Call Presentation

Q3 2025 EARNINGS CALL ELI LILLY AND COMPANY Agenda Introduction and Key Events Dave Ricks, Chair and Chief Executive Officer Q3 2025 Financial Results Lucas Montarce, Chief Financial Officer R&D Update Dan Skovronsky, M.D., Ph.D., Chief Scientific Officer Question & Answer Session 3 2025 Q3 EARNINGS Safe Harbor Provision and Other Information This presentation contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various fact ...